225 related articles for article (PubMed ID: 8224732)
1. Multiple neuropeptide Y receptors are involved in cardiovascular regulation. Peripheral and central mechanisms.
Grundemar L; Håkanson R
Gen Pharmacol; 1993 Jul; 24(4):785-96. PubMed ID: 8224732
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y receptor subtypes, Y1 and Y2.
Wahlestedt C; Grundemar L; Håkanson R; Heilig M; Shen GH; Zukowska-Grojec Z; Reis DJ
Ann N Y Acad Sci; 1990; 611():7-26. PubMed ID: 2174225
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y and peptide YY: major modulators of gastrointestinal blood flow and function.
Sheikh SP
Am J Physiol; 1991 Nov; 261(5 Pt 1):G701-15. PubMed ID: 1659217
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
Lundberg JM; Modin A
Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
[TBL] [Abstract][Full Text] [Related]
5. Ligand binding and functional effects of systematic double D-amino acid residue substituted neuropeptide Y analogs on Y1 and Y2 receptor types.
Grundemar L; Kahl U; Callréus T; Langel U; Bienert M; Beyermann M
Regul Pept; 1996 Apr; 62(2-3):131-6. PubMed ID: 8795076
[TBL] [Abstract][Full Text] [Related]
6. Activation of neuropeptide Y1 and neuropeptide Y2 receptors by substituted and truncated neuropeptide Y analogs: identification of signal epitopes.
Grundemar L; Krstenansky JL; Håkanson R
Eur J Pharmacol; 1993 Mar; 232(2-3):271-8. PubMed ID: 8467862
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem.
Glaum SR; Miller RJ; Rhim H; Maclean D; Georgic LM; MacKenzie RG; Grundemar L
Br J Pharmacol; 1997 Feb; 120(3):481-7. PubMed ID: 9031753
[TBL] [Abstract][Full Text] [Related]
8. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type.
Larhammar D; Blomqvist AG; Yee F; Jazin E; Yoo H; Wahlested C
J Biol Chem; 1992 Jun; 267(16):10935-8. PubMed ID: 1317848
[TBL] [Abstract][Full Text] [Related]
9. Identification of cultured cells selectively expressing Y1-, Y2-, or Y3-type receptors for neuropeptide Y/peptide YY.
Wahlestedt C; Regunathan S; Reis DJ
Life Sci; 1992; 50(4):PL7-12. PubMed ID: 1310131
[TBL] [Abstract][Full Text] [Related]
10. Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system.
Larsen PJ; Sheikh SP; Jakobsen CR; Schwartz TW; Mikkelsen JD
Eur J Neurosci; 1993 Dec; 5(12):1622-37. PubMed ID: 8124516
[TBL] [Abstract][Full Text] [Related]
11. PYY and NPY: control of gastric motility via action on Y1 and Y2 receptors in the DVC.
Chen CH; Stephens RL; Rogers RC
Neurogastroenterol Motil; 1997 Jun; 9(2):109-16. PubMed ID: 9198086
[TBL] [Abstract][Full Text] [Related]
12. Characterization and molecular cloning of vascular neuropeptide Y receptor subtypes in pig and dog.
Malmström RE; Hökfelt T; Björkman JA; Nihlén C; Byström M; Ekstrand AJ; Lundberg JM
Regul Pept; 1998 Sep; 75-76():55-70. PubMed ID: 9802394
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide Y: some viewpoints on a multifaceted peptide in the normal and diseased nervous system.
Hökfelt T; Broberger C; Zhang X; Diez M; Kopp J; Xu Z; Landry M; Bao L; Schalling M; Koistinaho J; DeArmond SJ; Prusiner S; Gong J; Walsh JH
Brain Res Brain Res Rev; 1998 May; 26(2-3):154-66. PubMed ID: 9651513
[TBL] [Abstract][Full Text] [Related]
14. Expression cloning of a human brain neuropeptide Y Y2 receptor.
Gehlert DR; Beavers LS; Johnson D; Gackenheimer SL; Schober DA; Gadski RA
Mol Pharmacol; 1996 Feb; 49(2):224-8. PubMed ID: 8632753
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
Malmström RE
Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).
Spinazzi R; Andreis PG; Nussdorfer GG
Int J Mol Med; 2005 Jan; 15(1):3-13. PubMed ID: 15583821
[TBL] [Abstract][Full Text] [Related]
17. Identification of positions in the human neuropeptide Y/peptide YY receptor Y2 that contribute to pharmacological differences between receptor subtypes.
Fällmar H; Åkerberg H; Gutiérrez-de-Terán H; Lundell I; Mohell N; Larhammar D
Neuropeptides; 2011 Aug; 45(4):293-300. PubMed ID: 21696823
[TBL] [Abstract][Full Text] [Related]
18. Y1 and Y2 receptor selective neuropeptide Y analogues: evidence for a Y1 receptor subclass.
Kirby DA; Koerber SC; May JM; Hagaman C; Cullen MJ; Pelleymounter MA; Rivier JE
J Med Chem; 1995 Oct; 38(22):4579-86. PubMed ID: 7473586
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/5 receptors.
Dimitrijević M; Stanojević S; Vujić V; Beck-Sickinger A; von Hörsten S
Regul Pept; 2005 Jan; 124(1-3):163-72. PubMed ID: 15544855
[TBL] [Abstract][Full Text] [Related]
20. Functional effects and ligand binding of chimeric galanin-neuropeptide Y (NPY) peptides on NPY and galanin receptor types.
Kahl U; Langel U; Bartfai T; Grundemar L
Br J Pharmacol; 1994 Apr; 111(4):1129-34. PubMed ID: 7518295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]